Collegium Pharma (COLL) Tops Q4 EPS by 3c

Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($0.54), $0.03 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $9.88 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Keurig Dr Pepper (KDP) PT Raised to $39 at Bernstein SocGen Group
• Hyperscale Data holds 2026 revenue guidance at $180M-$200M